These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19571794)

  • 1. Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.
    Kuczenski R; Segal DS; Melega WP; Lacan G; McCunney SJ
    Neuropsychopharmacology; 2009 Oct; 34(11):2430-41. PubMed ID: 19571794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
    O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
    Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
    Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
    Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration.
    Laćan G; Hadamitzky M; Kuczenski R; Melega WP
    Synapse; 2013 Aug; 67(8):476-88. PubMed ID: 23417852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance.
    Segal DS; Kuczenski R
    Neuropsychopharmacology; 2006 May; 31(5):941-55. PubMed ID: 16123749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.
    Schweppe CA; Burzynski C; Jayanthi S; Ladenheim B; Cadet JL; Gardner EL; Xi ZX; van Praag H; Newman AH; Keck TM
    Psychopharmacology (Berl); 2020 Jul; 237(7):1989-2005. PubMed ID: 32388619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization.
    Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
    Psychopharmacology (Berl); 2005 Jul; 180(3):501-12. PubMed ID: 15959831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.
    Melega WP; Jorgensen MJ; Laćan G; Way BM; Pham J; Morton G; Cho AK; Fairbanks LA
    Neuropsychopharmacology; 2008 May; 33(6):1441-52. PubMed ID: 17625500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges.
    Graham DL; Noailles PA; Cadet JL
    J Neurochem; 2008 Jun; 105(5):1873-85. PubMed ID: 18248616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of stereotyped behaviors during prolonged escalation of methamphetamine self-administration in rats.
    Hadamitzky M; McCunney S; Markou A; Kuczenski R
    Psychopharmacology (Berl); 2012 Oct; 223(3):259-69. PubMed ID: 22526541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens.
    Belcher AM; Feinstein EM; O'Dell SJ; Marshall JF
    Neuropsychopharmacology; 2008 May; 33(6):1453-63. PubMed ID: 17637607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile.
    Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1999 Oct; 291(1):19-30. PubMed ID: 10490882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
    Rivière GJ; Byrnes KA; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling human methamphetamine use patterns in mice: chronic and binge methamphetamine exposure, reward function and neurochemistry.
    Kesby JP; Chang A; Markou A; Semenova S
    Addict Biol; 2018 Jan; 23(1):206-218. PubMed ID: 28224681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
    Cho AK; Melega WP; Kuczenski R; Segal DS
    Synapse; 2001 Feb; 39(2):161-6. PubMed ID: 11180503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
    Broom SL; Yamamoto BK
    Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.